He, C., Sun, X., Qiao, H., Jiang, X., Wang, D., Jin, X., . . . Sun, X. (2012). Downregulating hypoxia‐inducible factor‐2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. Cancer Sci.
Παραπομπή Chicago StyleHe, Changjun, et al. "Downregulating Hypoxia‐inducible Factor‐2α Improves the Efficacy of Doxorubicin in the Treatment of Hepatocellular Carcinoma." Cancer Sci 2012.
Παραπομπή MLAHe, Changjun, et al. "Downregulating Hypoxia‐inducible Factor‐2α Improves the Efficacy of Doxorubicin in the Treatment of Hepatocellular Carcinoma." Cancer Sci 2012.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.